Independent analysis puts a SGN survodutide lot at 96.5%, against 95.8% on the certificate
The result is unremarkable. What the report omits is not.
Archive — September 2024
Page 4 of 5 of this archive, newest first.
Inspectors cite the online reseller trading as Adamant Research Supply over sterility assurance
The observation that closes a facility is rarely the dramatic one.
Before anything is weighed, the peptide has to be charged
A brief and unromantic tour of the interface between a liquid sample and a vacuum.
The substudies, read properly: who was scanned, when, and with what
Both the reassuring reading and the alarming reading are supportable from the same tables. This piece sets out which is which.
The dose that got you here and the dose that keeps you here
The commonest real-world strategy in this drug class is the least studied one.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
PeptideMeter result on a Guangzhou cagrilintide lot lands 3.7 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
What changed at HJ in September, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The consolidator trading as Meridian Freight Partners enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Every fortnight, every third week, seasonally: an unstudied practice
An absence of evidence is not evidence of harm. It is also not a licence.
The question no chromatogram has ever answered
The Journal has read several hundred certificates from twenty companies. We set out what the documents actually cover, and what a reader is filling in from imagination.
Inspectors cite Calder Vale Peptides of Skipton over sterility assurance
The observation that closes a facility is rarely the dramatic one.
Norway declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
FLOW misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Switzerland pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
The submitted sample: the weakest link in the whole system
A result on one vial generalises to a batch only if the vial was drawn in a way that makes it representative — and nobody records how it was drawn.
South Korea caps tirzepatide prescribing to 19 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Brazil caps semaglutide prescribing to 10 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What changed at ERP in September, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What the new Singapore guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Stepping down against stopping: two decisions treated as one
The best argument for tapering is behavioural rather than pharmacological, and it deserves to be made on its own terms.
Gallstones during rapid weight loss: drug, or weight loss?
Pancreatitis is rare, was adjudicated in the outcome programmes, and did not show the imbalance early case reports suggested.
What actually helps, ranked by evidence
The intervention with the clearest evidence is the one nobody frames as an intervention: adjusting the dose.
Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Spain pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
STEP 4 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A tested vial is evidence about a vial
The condition on arrival is recorded by some services and not others, and it is one of the more informative lines in a report.
What the four services actually offer, test by test
We asked all four services what they can determine, on what timescale, at what price, and under what accreditation. The answers are printed in full.
Inspectors cite Halvard & Pike Apothecary of Portland, Maine over sterility assurance
The observation that closes a facility is rarely the dramatic one.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
SURMOUNT-1 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The United Kingdom health authority warns on falsified dulaglutide pens
Reported from the analysis, not from a warning notice.
A certificate is a snapshot, and peptides do not stand still
A document is only as good as the chain that connects it to the material, and most chains here are two or three links longer than the paperwork admits.
The lowest effective dose is a real concept with almost no data behind it
Dose reduction is not withdrawal, and the trials that tested withdrawal cannot be read as testing it.
Japan caps liraglutide prescribing to 23 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What changed at GGPeps in September, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at JEEP in September, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What STEP 4 tells us about maintenance, and what it does not
A survey of the maintenance evidence, which is shorter than the survey of the withdrawal evidence.
The badge is about a sample. The listing is about a product.
Every step between the laboratory report and the product page removes information, and the badge is the last step.